Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are ...

Conference on HIV Science (IAS 2025) concluded in Kigali after five dynamic days (July 13-17), delegates left with a mix of hope and concern--buoyed by scientific breakthroughs but unsettled by a ...

The initiative will include the production of the newly approved injectable drug for HIV prevention – Lenacapavir ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

MELODY CHIRONDA | The Joint United Nations Programme on HIV/AIDS (UNAIDS) has warned that the global AIDS response is in ...

SAO PAULO, BRAZIL - A new HIV prevention drug, lenacapavir, is being called a major breakthrough. The WHO has released new ...

Thailand is examining the feasibility of adopting new global guidelines on long-acting HIV prevention, following the World Health Organisation's (WHO) launch of its latest recommendations for ...

WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.